0009K0 — Aimed Bio Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩4tn
- KR₩4tn
- KR₩12bn
Annual cashflow statement for Aimed Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -9,030 | -3,313 |
| Depreciation | ||
| Amortisation | ||
| Non-Cash Items | 3,698 | 3,704 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 1,629 | -6,728 |
| Change in Accounts Receivable | ||
| Change in Prepaid Expenses | ||
| Change in Accounts Payable | ||
| Change in Accrued Expenses | ||
| Change in Other Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -2,644 | -4,874 |
| Capital Expenditures | -796 | -1,680 |
| Purchase of Fixed Assets | ||
| Purchase / Acquisition of Intangibles | ||
| Other Investing Cash Flow Items | -13,704 | -14,709 |
| Sale of Fixed Assets | ||
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | -14,500 | -16,389 |
| Financing Cash Flow Items | 76.8 | — |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 15,734 | 24,270 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -1,410 | 3,026 |